Discharge is a high-risk time for opioid patients - what clinicians can do
Patients with opioid use disorder are at high risk of overdose after hospital discharge. Dr. Tom Robey shares strategies including bridge care, follow-up, and naloxone.
Patients with opioid use disorder are at high risk of overdose after hospital discharge. Dr. Tom Robey shares strategies including bridge care, follow-up, and naloxone.
Patient-facing information about fentanyl, xylazine (tranq), counterfeit pills, overdose risk, and harm reduction.
A patient-facing resource on self-compassion and stigma reduction for people with substance use disorder (SUD) or opioid use disorder (OUD).
Guidance for providing medications for opioid use disorder (MOUD), sometimes called MAT, in the emergency department, including buprenorphine and methadone.
Precipitated withdrawal is not a buprenorphine failure - it's a signal to adjust doses and provide personalized care. Dr. Tom Robey explains the science behind it and practical dosing strategies during induction.
While methadone often carries stigma, it can be the best treatment option for certain patients. Dr. Tom Robey explains when it may be the right MAT option and how it differs from buprenorphine.
In today's fentanyl-dominated drug supply, historical buprenorphine doses may not be enough. Dr. Tom Robey explains why higher doses can be safe and provides guidance on high-dose buprenorphine.
ScalaNW's approach to compassionate, evidence-based care for people with opioid use disorder (OUD), including MOUD, harm reduction, and stigma reduction.
Dr. Tom Robey, Emergency and Street Medicine Physician, introduces buprenorphine and explains why it matters and how to start it safely in the emergency department as MOUD (sometimes called MAT).
Managing withdrawal in pregnant patients with opioid use disorder (OUD).